|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 137.5 TWD | +5.77% |
|
+33.50% | +232.93% |
| 05-13 | Easywell Biomedicals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 05-08 | Easywell Biomedicals, Inc. announced a financing transaction | CI |
Easywell Biomedicals, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was TWD 73.42 million compared to TWD 36.97 million a year ago. Net loss was TWD 48.17 million compared to TWD 48.71 million a year ago.
Basic loss per share from continuing operations was TWD 0.41 compared to TWD 0.43 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +232.93% | 488M | |
| +56.86% | 815B | |
| +43.90% | 641B | |
| -6.57% | 352B | |
| +17.32% | 314B | |
| +9.94% | 303B | |
| +16.08% | 242B | |
| +2.29% | 224B | |
| +13.96% | 218B | |
| +7.98% | 168B |
EASYWELL BIOMEDICALS, INC. 
